Related Experiment Videos
Transforming growth factor-beta 1 in the human endometrium
V Polli1, C Bulletti, A Galassi
1Department of Obstetrics and Gynecology, University of Bologna, Italy.
Summary
Transforming growth factor-beta 1 (TGF-beta 1) is crucial for embryo implantation. Its levels in uterine fluid vary, and low TGF-beta 1 may cause implantation failure.
Area of Science:
- Reproductive Biology
- Endocrinology
- Immunology
Background:
- Transforming growth factor-beta 1 (TGF-beta 1) is a key polypeptide regulating physiological and pathophysiological processes, including embryo implantation.
- TGF-beta 1 plays multifaceted roles in both endometrial and embryonic tissues, influencing proliferation, differentiation, proteolytic activity, and maternal immune response.
Purpose of the Study:
- To evaluate the presence and modulation of TGF-beta 1 in the endometrium during normal menstrual cycles.
- To quantify TGF-beta 1 levels in uterine fluids during ovulation induction for in vitro fertilization (IVF).
- To investigate the potential link between TGF-beta 1 expression and implantation success.
Main Methods:
- Immunohistochemistry was employed to detect TGF-beta 1 in endometrial tissue.
- Immunodot-blot assay was utilized to quantify TGF-beta 1 in uterine cavity fluid.
- Study involved assessment during normal menstrual cycles and IVF procedures.
Main Results:
- TGF-beta 1 was confirmed in endometrial tissue, with its secretion showing cyclical modulation.
- Evidence suggests ovarian steroids control TGF-beta 1 production.
- Significant variability in TGF-beta 1 concentration was observed within the uterine cavity.
Conclusions:
- TGF-beta 1 is integral to embryo growth, differentiation, proteolytic enzyme activation, and maternal-embryonic immune modulation.
- The study demonstrates TGF-beta 1's dynamic presence in the uterine cavity.
- Underexpression of TGF-beta 1 in the uterine cavity is a potential factor contributing to failed implantation.